Presentation is loading. Please wait.

Presentation is loading. Please wait.

Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis  Jose A. Diaz, MD, Nicole E. Ballard-Lipka, BS,

Published byLester Elliott Modified over 6 years ago

Similar presentations

Presentation on theme: "Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis  Jose A. Diaz, MD, Nicole E. Ballard-Lipka, BS,"— Presentation transcript:

1 Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis  Jose A. Diaz, MD, Nicole E. Ballard-Lipka, BS, Diana M. Farris, LVT, Angela E. Hawley, MS, Shirley K. Wrobleski, BS, Daniel D. Myers, DVM, Peter K. Henke, MD, Daniel A. Lawrence, PhD, Thomas W. Wakefield, MD  Journal of Vascular Surgery  Volume 55, Issue 3, Pages (March 2012) DOI: /j.jvs Copyright © 2012 Society for Vascular Surgery Terms and Conditions

2 Fig 1 Thrombus size was increased in mice with hyperlipidemia. The thrombus weight was significantly increased by 14%, in apolipoprotein E gene-deleted (ApoE-/-) mice at day 2 (P < .05), and by 24% at day 14 (P < .01), vs wild type (WT). No differences were observed at day 6 between ApoE-/- and WT mice. In plasminogen activator inhibitor-1 gene deleted (PAI-1-/-) mice, the thrombus weight was significantly decreased at all time points compared with ApoE-/-, 45% at day 2 (P < .01); 33% at day 6 (P < .01) and 41% at day 14 (P < .01). TC, True controls. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

3 Fig 2 The fibrinolytic system was impaired mainly at acute time point in mice with hyperlipidemia. A, A trend of decreased plasmin levels in apolipoprotein E gene-deleted (ApoE-/-) mice compared with wild type (WT) was noted; 19% at day 2, 13% at day 6, and 22% at day 14. B, Levels of plasminogen activator inhibitor-1 (PAI-1) were significantly increased by 41% in ApoE-/-mice, vs WT at day 2 (P < .05). No significant differences were observed at days 6 and 14, post deep vein thrombosis (DVT). TC, True controls. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

4 Fig 3 The urokinase-type plasminogen activator (u-PA) system was impaired in mice with hyperlipidemia. A, This graph showed that it was possible to quantify levels of u-PA in both vein wall and thrombus in C57BL/6 mice. B, Using the same assay for apolipoprotein E gene-deleted (ApoE-/-) mice, undetectable levels of u-PA were found at all time points in both the vein wall and thrombus. TC, True controls. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

5 Fig 4 The decreased urokinase-type plasminogen activator (u-PA) system activity was reflected by matrix metalloproteinases (MMPs) in apolipoprotein E gene-deleted (ApoE-/-) mice. Zymography results: A, Graph showing that the protein concentration of MMP-2 was significantly decreased at days 6 and 14 in the vein wall. B, Graph showing the protein concentration of MMP-9 in the vein wall. It was significantly decreased at day 2 and day 6. TC, True controls. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

6 Fig 5 The decreased urokinase-type plasminogen activator (u-PA) system activity was reflected by monocyte chemotactic protein-1 (MCP-1) and monocyte recruitment in mice with hyperlipidemia. A, This graph shows the vein wall protein concentration of MCP-1 to be significantly decreased by 38% at day 2 (P < .01) and by 67% at day 6 (P < .01) after deep vein thrombosis (DVT) in apolipoprotein E gene-deleted (ApoE-/-) mice vs wild type (WT). B, Monocyte cell counts, average counts of 5 high-power fields (HPF) in at least five specimens per each time point, were significantly reduced at day 6 (P < .01) and day 14 (P < .05) in mice with hyperlipidemia vs controls. TC, True controls. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

7 Fig 6 Schematic representation of our findings. Fibrinolysis and thrombus resolution were found to be impaired in mice with hyperlipidemia undergoing deep vein thrombosis (DVT). Increased plasminogen activator inhibitor-1 (PAI-1) contributes to an early increase in thrombus size, due to impaired fibrinolysis. Additionally, undetectable levels of urokinase-type plasminogen activator (u-PA) led to decreased vein wall matrix metalloproteinase (MMP)-2 and MMP-9, and lower levels of monocyte chemotactic protein-1 (MCP-1) affecting monocyte recruitment, thus impairing thrombus resolution. ApoE-/-, Apolipoprotein E gene-deleted. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Download ppt "Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis  Jose A. Diaz, MD, Nicole E. Ballard-Lipka, BS,"

Similar presentations

Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages 1072-1082 (October 2014) DOI:

Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages (October 2014) DOI:
Intermittent pneumatic compression of the foot and calf improves the outcome of catheter-directed thrombolysis using low-dose urokinase in patients with.

Intermittent pneumatic compression of the foot and calf improves the outcome of catheter-directed thrombolysis using low-dose urokinase in patients with.
Without prejudice Journal of Vascular Surgery

Without prejudice Journal of Vascular Surgery
Experimental pulmonary embolism: Effects of the thrombus and attenuation of pulmonary artery injury by low-molecular-weight heparin  John E. Rectenwald,

Experimental pulmonary embolism: Effects of the thrombus and attenuation of pulmonary artery injury by low-molecular-weight heparin  John E. Rectenwald,
Vein wall re-endothelialization after deep vein thrombosis is improved with low- molecular-weight heparin  Daria K. Moaveni, MD, Erin M. Lynch, MS, Cathy.

Vein wall re-endothelialization after deep vein thrombosis is improved with low- molecular-weight heparin  Daria K. Moaveni, MD, Erin M. Lynch, MS, Cathy.
Recurrent thromboembolism in patients with vena cava filters

Recurrent thromboembolism in patients with vena cava filters
Regulation of vascular smooth muscle cell expression and function of matrix metalloproteinases is mediated by estrogen and progesterone exposure  Oscar.

Regulation of vascular smooth muscle cell expression and function of matrix metalloproteinases is mediated by estrogen and progesterone exposure  Oscar.
National trends in venous disease

National trends in venous disease
Soft tissue sarcomas may present with deep vein thrombosis

Soft tissue sarcomas may present with deep vein thrombosis
Comparison of vein valve function following pharmacomechanical thrombolysis versus simple catheter-directed thrombolysis for iliofemoral deep vein thrombosis 

Comparison of vein valve function following pharmacomechanical thrombolysis versus simple catheter-directed thrombolysis for iliofemoral deep vein thrombosis 
Osama M. El-Sayed, BS, Nicholas A. Dewyer, MD, Catherine E

Osama M. El-Sayed, BS, Nicholas A. Dewyer, MD, Catherine E
Incidence of and risk factors for iliocaval venous obstruction in patients with active or healed venous leg ulcers  William Marston, MD, Daniel Fish,

Incidence of and risk factors for iliocaval venous obstruction in patients with active or healed venous leg ulcers  William Marston, MD, Daniel Fish,
Loss of STAT1 is associated with increased aortic rupture in an experimental model of aortic dissection and aneurysm formation  Matthew J. Eagleton, MD,

Loss of STAT1 is associated with increased aortic rupture in an experimental model of aortic dissection and aneurysm formation  Matthew J. Eagleton, MD,
Direct thrombolytic therapy in portal and mesenteric vein thrombosis

Direct thrombolytic therapy in portal and mesenteric vein thrombosis
Tamoxifen up-regulates catalase production, inhibits vessel wall neutrophil infiltration, and attenuates development of experimental abdominal aortic.

Tamoxifen up-regulates catalase production, inhibits vessel wall neutrophil infiltration, and attenuates development of experimental abdominal aortic.
Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model  Jianping Dai, MD, PhD, Liliane.

Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model  Jianping Dai, MD, PhD, Liliane.
Jeanwan Kang, MD, Hassan Albadawi, MD, Virendra I. Patel, MD, Thomas A

Jeanwan Kang, MD, Hassan Albadawi, MD, Virendra I. Patel, MD, Thomas A
Postthrombotic vein wall remodeling: Preliminary observations

Postthrombotic vein wall remodeling: Preliminary observations
Controlled release of ascorbic acid from gelatin hydrogel attenuates abdominal aortic aneurysm formation in rat experimental abdominal aortic aneurysm.

Controlled release of ascorbic acid from gelatin hydrogel attenuates abdominal aortic aneurysm formation in rat experimental abdominal aortic aneurysm.
Deep venous thrombosis after repair of nonruptured abdominal aneurysm

Deep venous thrombosis after repair of nonruptured abdominal aneurysm

Similar presentations

Ads by Google